etanercept,free,encyclopedia,skin,stylepath,wgarticlepath,wgscriptpath,wgscript,wgvariantarticlepath,wgactionpaths,wgserver,wgcanonicalnamespace,wgcanonicalspecialpagename,wgnamespacenumber,wgpagename,wgtitle,wgaction,wgarticleid,wgisarticle,wgusername,wgusergroups,wguserlanguage,wgcontentlanguage,wgbreakframes,wgcurrevisionid,wgversion,wgenableapi,wgenablewriteapi,wgseparatortransformtable,wgdigittransformtable,wgmwsuggesttemplate,wgdbname,wgsearchnamespaces,wgmwsuggestmessages,wgrestrictionedit,wgrestrictionmove,wikibits,js,site,js,etanercept,free,encyclopedia,jump,search,etanercept,systematic,name,unable,assigned,identifiers,cas,number,atc,code,l04ab01,pubchem,drugbank,btd00052,chemical,data,formula,mass,pharmacokinetic,data,bioavailability,metabolism,reticuloendothelial,system,half,life,hours,excretion,therapeutic,considerations,pregnancy,b2,b,legal,status,s4,pom,routes,subcutaneous,etanercept,drug,treats,autoimmune,diseases,interfering,tnf,part,immune,etanercept,drug,made,combining,two,proteins,fusion,links,human,soluble,tnf,receptor,fc,component,human,immunoglobulin,g1,acts,tnf,prototypic,fusion,protein,first,synthesized,shown,highly,active,unusually,stable,modality,blockade,tnf,vivo,early,1990s,bruce,academic,researcher,university,texas,southwestern,medical,center,investigators,patented,selling,rights,use,biotechnology,company,acquired,amgen,large,molecular,weight,150,binds,decreases,role,disorders,involving,excess,inflammation,humans,including,autoimmune,diseases,ankylosing,juvenile,rheumatoid,psoriatic,rheumatoid,variety,disorders,mediated,excess,therapeutic,potential,based,fact,coined,marc,ravinder,maini,recipients,2003,lasker,award,research,rheumatoid,inflammatory,response,many,organ,north,etanercept,amgen,wyeth,trade,name,enbrel,two,separate,one,powder,wyeth,sole,marketer,enbrel,outside,north,contents,1,development,2,mode,action,3,structure,4,licensed,indications,5,administration,6,safety,7,sales,8,uses,9,similar,agents,10,references,11,external,links,tocshowtext,tochidetext,development,etanercept,developed,researchers,released,commercial,use,late,soon,release,infliximab,first,chimeric,monoclonal,antibody,marketed,clinical,etanercept,dimeric,dimeric,structure,necessary,proper,therapeutic,development,immunex,corporation,earlier,monomeric,version,sufficient,biologic,mode,action,reduces,effect,naturally,present,hence,tnf,tumor,necrosis,cytokine,produced,monocytes,two,types,white,blood,mediates,immune,response,increasing,transport,white,blood,cells,sites,additional,molecular,mechanisms,initiate,amplify,inhibition,action,etanercept,reduces,inflammatory,response,especially,useful,treating,autoimmune,two,types,tnf,found,embedded,white,blood,cells,respond,tnf,releasing,soluble,tnf,receptors,used,deactivate,tnf,blunt,immune,tnf,receptors,found,surface,virtually,nucleated,cells,blood,contain,tnf,receptors,etanercept,mimics,inhibitory,effects,naturally,occurring,soluble,tnf,difference,fusion,protein,rather,simple,tnf,greatly,extended,therefore,profound,biologic,effect,naturally,occurring,soluble,tnf,structure,etanercept,made,combination,two,naturally,occurring,soluble,human,tnf,receptors,linked,fc,portion,effect,artificially,engineered,dimeric,fusion,licensed,indications,usa,fda,licenced,enbrel,moderate,severe,rheumatoid,arthritis,moderate,severe,polyarticular,juvenile,idiopathic,arthritis,psoriatic,arthritis,ankylosing,spondylitis,moderate,severe,plaque,psoriasis,administration,enbrel,marketed,lyophylized,powder,vials,must,reconstituted,diluent,injected,typically,patient,patients,arthritis,found,reconstitution,procedure,made,available,syringes,late,2004,autoinjector,brought,market,cannot,administered,digestive,system,would,destroy,fda,approved,dose,biw,qw,safety,tnf,inhibitors,number,studies,reports,adverse,reactions,patients,receiving,alpha,therapy,serious,sometimes,fatal,blood,rare,reports,lymphoma,solid,tissue,rare,reports,serious,liver,rare,reports,demyelinating,central,nervous,system,rare,reports,congestive,heart,food,drug,administration,issued,warning,doctors,appearing,respective,product,labeling,drugs,instructing,screen,monitor,potential,patients,although,three,agents,infliximab,adalimumab,biologic,methods,side,effect,profiles,somewhat,differences,may,accounted,fundamental,differences,biologic,infliximab,adalimumab,fix,ability,lyze,potentially,contributing,therapeutic,efficacy,disorders,disease,monoclonal,antibodies,mabs,carry,addition,infliximab,higher,propensity,development,perhaps,result,chimeric,structure,intravenous,route,may,fda,placed,black,box,warning,etanercept,due,number,serious,infections,associated,sales,enbrel,widely,used,biologic,drug,field,rheumatology,patients,taking,drug,indication,either,remicade,humira,however,infliximab,widely,used,biologic,drug,fda,approved,indications,drugs,including,disease,ulcerative,two,autoimmune,diseases,etanercept,fda,approved,addition,labeled,multiple,scientific,studies,suggesting,potential,uses,fda,verified,either,safety,uses,given,central,role,many,etanercept,studied,treatment,number,including,150,clinical,includes,certain,forms,vasculitis,2006,pilot,study,showed,small,significant,improvements,various,cognitive,rating,scales,patients,disease,treatment,administering,single,patient,via,perispinal,showed,rapid,significant,improvement,small,number,us,physicians,offer,etanercept,treatment,cost,similar,agents,infliximab,adalimumab,certolizumab,pegol,references,wikimedia,commons,media,related,etanercept,tumor,necrosis,factor,heavy,chain,chimeric,protein,bivalent,antagonist,tnf,1991,expression,tnf,inhibitor,transgenic,1993,prolonged,effective,blockade,tumor,necrosis,factor,activity,gene,1994,patent,drug,effective,depression,psoriasis,retrieved,braun,mchugh,singh,wajdula,sato,r,outcomes,patients,ankylosing,spondylitis,treated,etanercept,50,mg,25,mg,rheumatology,46,pmid,defined,therapeutic,target,rheumatoid,arthritis,autoimmune,diseases,nature,retrieved,smith,skelton,hg,onset,cutaneous,squamous,cell,carcinoma,patients,rheumatoid,arthritis,starting,tumor,necrosis,factor,alpha,receptor,fusion,complex,45,pmid,madhusudan,muthuramalingam,braybrooke,tumor,necrosis,recurrent,ovarian,23,pmid,fda,humira,automated,delivery,retrieved,information,retrieved,amgen,heighten,warning,infections,skin,drug,retrieved,fda,clinical,trials,database,plus,standard,therapy,352,pmid,tobinick,edward,gross,weinberger,cohen,h,modulation,treatment,pilot,medgenmed,8,pmid,tobinick,edward,gross,cognitive,improvement,disease,following,perispinal,etanercept,neuroinflammation,5,pmid,external,links,enbrel,site,case,study,development,enbrel,acquisition,amgen,immunosuppressive,immunosuppressants,intracellular,antimetabolites,purine,synthesis,mycophenolic,acid,pyrimidine,synthesis,teriflunomide,methotrexate,inhibitors,pimecrolimus,gusperimus,inhibitor,lenalidomide,intracellular,receptor,antagonists,anakinra,mtor,zotarolimus,extracellular,antibodies,monoclonal,serum,target,complement,component,5,tnfs,certolizumab,interleukin,5,immunoglobulin,bayx,interferon,cellular,target,cd3,cd4,cd11a,cd18,cd20,cd23,cd40,cd80,cd154,blys,cat,integrin,receptor,unsorted,dorlimomab,telimomab,vepalimomab,polyclonal,globulin,tnf,inhibitor,retrieved,inhibitors,amgen,recombinant,proteins,monoclonal,antibodies,immunosuppressantshidden,pages,needing,cleanup,wikipedia,articles,needing,clarification,february,2009,articles,unsourced,statements,articles,unsourced,statements,since,june,2007,articles,unsourced,statements,since,january,2009,views,article,discussion,edit,page,history,personal,tools,log,create,account,navigation,main,page,contents,featured,content,current,events,random,article,search,interaction,wikipedia,community,portal,recent,changes,contact,wikipedia,donate,wikipedia,help,toolbox,links,related,changes,upload,file,special,pages,printable,version,permanent,linkcite,page,languages,deutsch,nederlands,polski,svenska,page,last,modified,2,april,text,available,terms,gnu,free,documentation,copyrights,registered,trademark,wikimedia,registered,nonprofit,privacy,policy,wikipedia,disclaimers,